spacer
The Healthcare Sales & Marketing Network celebrates 25 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Vical Inc 

 HSMN NewsFeed - 22 Jan 2018
Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients
Biopharmaceuticals
 HSMN NewsFeed - 30 Jan 2017
AmpliPhi Biosciences Appoints Dr. Igor P. Bilinsky as Senior Vice President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Sep 2015
Ignyta Appoints Igor Bilinsky as General Manager, Immuno-Oncology and Senior Vice President, Special Operations
Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 5 Sep 2013
Immune Design Appoints Richard T. Kenney, M.D., Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Nov 2012
Vical Names Mammen P. Mammen, Jr., M.D., Vice President, Clinical Vaccines
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Apr 2011
NeurogesX CEO Anthony DiTonno to Retire by Year End
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Apr 2011
Raptor Pharmaceutical Adds Three Biopharmaceutical Leaders to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Mar 2011
KaloBios Announces Two Significant Additions to Its Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Oct 2010
Vical Names Igor Bilinsky Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2007
Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Biopharmaceuticals
 HSMN NewsFeed - 20 Aug 2007
Vical Names Andrew de Guttadauro Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 May 2007
BrainCells Names Seth D. Goldblum VP, Business Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 May 2007
Vical's Vaxfectin(TM) Adjuvant With Needle-free Delivery Enhances DNA Vaccine Performance; Yields Antibody Responses Comparable to Electroporation Without Tolerability Issues
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 26 Mar 2007
USDA Grants Conditional Approval for First Therapeutic Vaccine to Treat Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 24 Jan 2007
Vical Highlights Transition to Phase 3 Trial With Allovectin-7(R) for Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Jan 2007
Vical Initiates Pivotal Phase 3 Trial of Allovectin-7(R) as First-line Therapy for Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Nov 2006
Bioject Signs Agreement With Vical
Devices Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 21 Jul 2006
Vical Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Jun 2006
Vical Names Ronald B. Moss, M.D., Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Mar 2006
Vical Licensee sanofi-aventis Releases Phase 2b Angiogenesis Data and Plans for Phase 3
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 6

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 6 additional stories matching:
Vical Inc
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.